| pigmentation | GO:0043473 | 71 | 0.889 | Mouse |
| embryonic heart tube left right pattern formation | GO:0060971 | 5 | 0.849 | |
| regionalization | GO:0003002 | 337 | 0.812 | |
| determination of digestive tract left right asymmetry | GO:0071907 | 1 | 0.672 | |
| lung development | GO:0030324 | 164 | 0.591 | |
| embryonic heart tube anterior posterior pattern specification | GO:0035054 | 3 | 0.579 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.544 | |
| positive regulation of axon extension | GO:0045773 | 20 | 0.518 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.506 | |
| clara cell differentiation | GO:0060486 | 4 | 0.493 | |
| heart morphogenesis | GO:0003007 | 178 | 0.452 | |
| cardioblast migration to the midline involved in heart field formation | GO:0060975 | 1 | 0.434 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.430 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.421 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.418 | |
| mesendoderm development | GO:0048382 | 3 | 0.397 | |
| gland development | GO:0048732 | 330 | 0.376 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.376 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.365 | |
| germ line stem cell division | GO:0042078 | 2 | 0.359 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.348 | |
| left right pattern formation | GO:0060972 | 23 | 0.340 | |
| mesenchyme development | GO:0060485 | 152 | 0.339 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.338 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.331 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.322 | |
| bone morphogenesis | GO:0060349 | 78 | 0.316 | |
| segmentation | GO:0035282 | 93 | 0.293 | |
| embryonic placenta development | GO:0001892 | 98 | 0.290 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.285 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.270 | |
| vascular smooth muscle cell differentiation | GO:0035886 | 11 | 0.259 | |
| atrial septum primum morphogenesis | GO:0003289 | 3 | 0.259 | |
| negative regulation of glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | GO:2000734 | 1 | 0.253 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.250 | |
| response to peptide | GO:1901652 | 136 | 0.247 | Mouse |
| heart field specification | GO:0003128 | 6 | 0.246 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.242 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.234 | |
| transmembrane transport | GO:0055085 | 412 | 0.232 | |
| bone development | GO:0060348 | 120 | 0.228 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.212 | |
| secondary heart field specification | GO:0003139 | 6 | 0.211 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.208 | |
| positive regulation of axon guidance | GO:1902669 | 5 | 0.207 | |
| sperm ejaculation | GO:0042713 | 1 | 0.205 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.204 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.197 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.193 | |
| cell migration involved in gastrulation | GO:0042074 | 13 | 0.187 | |
| cardioblast migration | GO:0003260 | 1 | 0.183 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.183 | |
| digestive system development | GO:0055123 | 200 | 0.182 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.182 | |
| protein ubiquitination | GO:0016567 | 171 | 0.180 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.172 | |
| maintenance of location | GO:0051235 | 89 | 0.164 | |
| lipid storage | GO:0019915 | 36 | 0.161 | |
| respiratory system development | GO:0060541 | 190 | 0.158 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.158 | |
| cardiac vascular smooth muscle cell development | GO:0060948 | 3 | 0.155 | |
| glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | GO:2000701 | 1 | 0.154 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.153 | |
| midbrain hindbrain boundary morphogenesis | GO:0021555 | 4 | 0.151 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.149 | |
| cardiac cell fate determination | GO:0060913 | 2 | 0.148 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.148 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.146 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.143 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.142 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.142 | |
| nodal signaling pathway involved in determination of left right asymmetry | GO:0038107 | 2 | 0.141 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.141 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.140 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.139 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.137 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.137 | |
| trachea formation | GO:0060440 | 3 | 0.135 | |
| regulation of cell growth | GO:0001558 | 91 | 0.132 | |
| gonad development | GO:0008406 | 141 | 0.132 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.132 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.130 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.128 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.128 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.125 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.124 | |
| detection of chemical stimulus involved in sensory perception of taste | GO:0050912 | 3 | 0.124 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.121 | |
| protein targeting | GO:0006605 | 143 | 0.120 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.120 | |
| cell migration to the midline involved in heart development | GO:0003318 | 1 | 0.119 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.119 | |
| foregut morphogenesis | GO:0007440 | 12 | 0.119 | |
| kidney epithelium development | GO:0072073 | 121 | 0.118 | |
| venous blood vessel development | GO:0060841 | 13 | 0.117 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.117 | |
| multicellular organism growth | GO:0035264 | 161 | 0.116 | |
| gastrulation | GO:0007369 | 116 | 0.116 | |
| liver development | GO:0001889 | 66 | 0.115 | |
| female gonad development | GO:0008585 | 71 | 0.114 | |
| regulation of ion transport | GO:0043269 | 215 | 0.114 | |
| neural tube closure | GO:0001843 | 90 | 0.113 | |
| nephron development | GO:0072006 | 109 | 0.113 | |
| venous blood vessel morphogenesis | GO:0048845 | 7 | 0.111 | |
| blastocyst development | GO:0001824 | 80 | 0.110 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.109 | |
| humoral immune response | GO:0006959 | 57 | 0.109 | |
| response to growth factor | GO:0070848 | 198 | 0.109 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.108 | |
| cation homeostasis | GO:0055080 | 212 | 0.108 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.107 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.106 | |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.104 | |
| regulation of endodermal cell differentiation | GO:1903224 | 2 | 0.104 | |
| neural tube development | GO:0021915 | 160 | 0.104 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.103 | |
| lateral mesodermal cell differentiation | GO:0048371 | 3 | 0.103 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.102 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.101 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.101 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.100 | |
| lung alveolus development | GO:0048286 | 45 | 0.100 | |
| endodermal cell fate commitment | GO:0001711 | 12 | 0.100 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.099 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.098 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.098 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.097 | |
| respiratory tube development | GO:0030323 | 167 | 0.097 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.096 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.096 | |
| endothelial tube morphogenesis | GO:0061154 | 2 | 0.095 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.095 | |
| protein acylation | GO:0043543 | 64 | 0.094 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.094 | |
| placenta development | GO:0001890 | 140 | 0.094 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.093 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.093 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.092 | |
| nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry | GO:1900164 | 2 | 0.092 | |
| peptide metabolic process | GO:0006518 | 46 | 0.092 | |
| lung saccule development | GO:0060430 | 7 | 0.092 | |
| transcriptional activation by promoter enhancer looping | GO:0071733 | 2 | 0.091 | |
| response to oxidative stress | GO:0006979 | 123 | 0.091 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.091 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.090 | |
| ductus arteriosus closure | GO:0097070 | 3 | 0.088 | |
| protein localization to endosome | GO:0036010 | 2 | 0.088 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.088 | |
| stem cell differentiation | GO:0048863 | 268 | 0.087 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.087 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.086 | |
| response to peptide hormone | GO:0043434 | 127 | 0.086 | Mouse |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.086 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.086 | |
| myeloid dendritic cell activation | GO:0001773 | 25 | 0.086 | |
| chromatin modification | GO:0016568 | 187 | 0.086 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.086 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.085 | |
| negative regulation of macrophage differentiation | GO:0045650 | 4 | 0.085 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.084 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.083 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.083 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.082 | |
| myotube differentiation | GO:0014902 | 105 | 0.082 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.082 | Mouse |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.081 | |
| p38mapk cascade | GO:0038066 | 4 | 0.081 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.080 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.080 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.080 | |
| histone modification | GO:0016570 | 159 | 0.079 | |
| activin receptor signaling pathway | GO:0032924 | 18 | 0.079 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.079 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.079 | |
| regulation of transcription involved in primary germ layer cell fate commitment | GO:0060796 | 2 | 0.078 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.078 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.078 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.078 | |
| innate immune response | GO:0045087 | 157 | 0.078 | Mouse |
| gastrulation with mouth forming second | GO:0001702 | 29 | 0.078 | |
| lung lobe formation | GO:0060464 | 1 | 0.077 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.077 | |
| regulation of ureteric bud formation | GO:0072106 | 3 | 0.077 | |
| positive regulation of ureteric bud formation | GO:0072107 | 3 | 0.077 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.077 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.076 | |
| hypothalamus cell migration | GO:0021855 | 5 | 0.076 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.076 | |
| neural tube formation | GO:0001841 | 108 | 0.075 | |
| regulation of cell size | GO:0008361 | 72 | 0.074 | |
| otolith morphogenesis | GO:0032474 | 3 | 0.074 | |
| activation of immune response | GO:0002253 | 138 | 0.073 | |
| regulation of definitive erythrocyte differentiation | GO:0010724 | 3 | 0.073 | |
| endocardial cushion morphogenesis | GO:0003203 | 18 | 0.073 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.073 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.073 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.072 | |
| organ growth | GO:0035265 | 117 | 0.072 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.072 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.071 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.071 | |
| cardiac muscle hypertrophy in response to stress | GO:0014898 | 10 | 0.071 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.070 | |
| muscle system process | GO:0003012 | 141 | 0.070 | |
| germ line stem cell maintenance | GO:0030718 | 6 | 0.070 | |
| atrioventricular node development | GO:0003162 | 3 | 0.070 | |
| endothelial cell fate commitment | GO:0060839 | 2 | 0.070 | |
| floor plate morphogenesis | GO:0033505 | 3 | 0.069 | |
| pro t cell differentiation | GO:0002572 | 3 | 0.069 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.069 | Mouse |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.068 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.068 | |
| ammonia homeostasis | GO:0097272 | 1 | 0.068 | |
| mesoderm formation | GO:0001707 | 62 | 0.068 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.067 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.067 | |
| determination of left right asymmetry in nervous system | GO:0035545 | 1 | 0.067 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.067 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.066 | Human |
| wnt signaling pathway | GO:0016055 | 188 | 0.066 | |
| somite specification | GO:0001757 | 4 | 0.065 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.065 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.065 | |
| molting cycle | GO:0042303 | 90 | 0.064 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.064 | |
| nephrogenic mesenchyme morphogenesis | GO:0072134 | 2 | 0.064 | |
| artery development | GO:0060840 | 53 | 0.064 | |
| regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | GO:2000702 | 1 | 0.064 | |
| septum primum development | GO:0003284 | 4 | 0.063 | |
| dna metabolic process | GO:0006259 | 303 | 0.063 | |
| regulation of cell proliferation involved in mesonephros development | GO:2000606 | 1 | 0.063 | |
| heart process | GO:0003015 | 94 | 0.063 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.062 | |
| cardiac septum development | GO:0003279 | 59 | 0.062 | |
| regulation of forebrain neuron differentiation | GO:2000977 | 2 | 0.062 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.062 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.062 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.061 | |
| oocyte construction | GO:0007308 | 2 | 0.061 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.061 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.061 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.061 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.061 | |
| arterial endothelial cell differentiation | GO:0060842 | 5 | 0.061 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.060 | |
| endomembrane system organization | GO:0010256 | 147 | 0.060 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.060 | |
| male gonad development | GO:0008584 | 88 | 0.059 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.059 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.059 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.058 | |
| positive regulation of glial cell differentiation | GO:0045687 | 21 | 0.058 | |
| epithelial to mesenchymal transition involved in endocardial cushion formation | GO:0003198 | 10 | 0.058 | |
| gliogenesis | GO:0042063 | 141 | 0.058 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.058 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.058 | |
| cell proliferation involved in mesonephros development | GO:0061209 | 4 | 0.058 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.058 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.058 | |
| fasciculation of sensory neuron axon | GO:0097155 | 3 | 0.057 | |
| lateral mesoderm morphogenesis | GO:0048369 | 3 | 0.057 | |
| regulation of endodermal cell fate specification | GO:0042663 | 2 | 0.057 | |
| hormone secretion | GO:0046879 | 128 | 0.057 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.057 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.056 | |
| mating | GO:0007618 | 27 | 0.056 | |
| urea homeostasis | GO:0097274 | 2 | 0.056 | |
| chondrocyte hypertrophy | GO:0003415 | 4 | 0.056 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.056 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.056 | |
| fused antrum stage | GO:0048165 | 1 | 0.056 | |
| heart growth | GO:0060419 | 45 | 0.056 | |
| heart valve development | GO:0003170 | 23 | 0.056 | |
| skeletal system development | GO:0001501 | 356 | 0.055 | |
| telencephalon development | GO:0021537 | 186 | 0.055 | |
| canonical wnt signaling pathway involved in metanephric kidney development | GO:0061290 | 2 | 0.055 | |
| fat cell differentiation | GO:0045444 | 160 | 0.054 | |
| endocardial cushion formation | GO:0003272 | 13 | 0.054 | |
| coronary vasculature development | GO:0060976 | 12 | 0.054 | |
| ventricular trabecula myocardium morphogenesis | GO:0003222 | 11 | 0.054 | |
| pulmonary artery morphogenesis | GO:0061156 | 3 | 0.054 | |
| neuron projection guidance | GO:0097485 | 141 | 0.053 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.053 | |
| regulation of binding | GO:0051098 | 111 | 0.053 | |
| gene looping | GO:0090202 | 2 | 0.053 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.053 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.053 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.052 | |
| monocyte differentiation | GO:0030224 | 9 | 0.052 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.052 | |
| positive regulation of erythrocyte differentiation | GO:0045648 | 11 | 0.052 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.052 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.052 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.052 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.052 | |
| regulation of endothelial cell differentiation | GO:0045601 | 10 | 0.052 | |
| heart trabecula formation | GO:0060347 | 14 | 0.052 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.051 | |
| protein alkylation | GO:0008213 | 81 | 0.051 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.051 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.051 | |
| blood vessel endothelial cell differentiation | GO:0060837 | 6 | 0.051 | |
| endocardial cushion cell differentiation | GO:0061443 | 1 | 0.051 | |
| muscle adaptation | GO:0043500 | 39 | 0.051 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.051 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.050 | |
| regulation of secretion | GO:0051046 | 274 | 0.050 | |
| positive regulation of b cell tolerance induction | GO:0002663 | 2 | 0.050 | |
| neuropilin signaling pathway | GO:0038189 | 2 | 0.050 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.050 | |
| negative regulation of endothelial cell differentiation | GO:0045602 | 2 | 0.050 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.049 | |
| cellular homeostasis | GO:0019725 | 240 | 0.049 | |
| muscle tissue development | GO:0060537 | 308 | 0.049 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.049 | |
| negative regulation of mechanoreceptor differentiation | GO:0045632 | 3 | 0.049 | |
| metanephric s shaped body morphogenesis | GO:0072284 | 2 | 0.049 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.049 | |
| stem cell maintenance | GO:0019827 | 130 | 0.049 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.049 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.048 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.048 | |
| thymus development | GO:0048538 | 41 | 0.048 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.048 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.048 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.048 | |
| growth plate cartilage chondrocyte development | GO:0003431 | 3 | 0.048 | |
| endothelium development | GO:0003158 | 45 | 0.048 | |
| dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis | GO:0060598 | 2 | 0.048 | |
| male gamete generation | GO:0048232 | 285 | 0.048 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.048 | |
| positive regulation of binding | GO:0051099 | 49 | 0.047 | |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 15 | 0.047 | |
| growth involved in heart morphogenesis | GO:0003241 | 4 | 0.047 | |
| negative regulation of mesodermal cell fate specification | GO:0042662 | 3 | 0.047 | |
| regulation of defense response | GO:0031347 | 233 | 0.047 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.047 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.046 | |
| blood circulation | GO:0008015 | 195 | 0.046 | |
| positive regulation of tolerance induction to self antigen | GO:0002651 | 1 | 0.046 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 27 | 0.046 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.045 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.045 | |
| commitment of neuronal cell to specific neuron type in forebrain | GO:0021902 | 7 | 0.045 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.045 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.045 | |
| atrioventricular valve formation | GO:0003190 | 5 | 0.045 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.045 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.045 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.045 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.045 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.045 | |
| regulation of cell activation | GO:0050865 | 289 | 0.045 | |
| regulation of astrocyte differentiation | GO:0048710 | 20 | 0.045 | |
| stem cell development | GO:0048864 | 219 | 0.045 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.045 | |
| atrioventricular valve morphogenesis | GO:0003181 | 13 | 0.045 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.045 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.044 | |
| glial cell fate determination | GO:0007403 | 3 | 0.044 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.044 | |
| protein localization to membrane | GO:0072657 | 108 | 0.044 | |
| cardiac chamber development | GO:0003205 | 108 | 0.044 | |
| positive regulation of biomineral tissue development | GO:0070169 | 12 | 0.044 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.044 | |
| prechordal plate formation | GO:0021501 | 1 | 0.044 | |
| bone mineralization | GO:0030282 | 54 | 0.044 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.044 | |
| regulation of inositol 1 4 5 trisphosphate sensitive calcium release channel activity | GO:0031585 | 2 | 0.044 | |
| lipid localization | GO:0010876 | 126 | 0.044 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.044 | |
| response to inorganic substance | GO:0010035 | 96 | 0.044 | |
| renal system development | GO:0072001 | 225 | 0.044 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.043 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.043 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.043 | |
| histone acetylation | GO:0016573 | 41 | 0.043 | |
| wnt signaling pathway involved in kidney development | GO:0061289 | 2 | 0.043 | |
| striated muscle cell development | GO:0055002 | 125 | 0.043 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.043 | |
| lymph vessel morphogenesis | GO:0036303 | 11 | 0.043 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.043 | |
| amide transport | GO:0042886 | 138 | 0.042 | |
| cellular divalent inorganic anion homeostasis | GO:0072501 | 3 | 0.042 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.042 | |
| regulation of smad protein import into nucleus | GO:0060390 | 3 | 0.042 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 13 | 0.042 | |
| epidermis development | GO:0008544 | 187 | 0.042 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.042 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.042 | |
| retina vasculature development in camera type eye | GO:0061298 | 17 | 0.042 | |
| endoderm development | GO:0007492 | 45 | 0.042 | |
| regulation of b cell tolerance induction | GO:0002661 | 2 | 0.042 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.041 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.041 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.041 | |
| compartment pattern specification | GO:0007386 | 4 | 0.041 | |
| embryonic neurocranium morphogenesis | GO:0048702 | 3 | 0.041 | |
| heart formation | GO:0060914 | 16 | 0.041 | |
| immune effector process | GO:0002252 | 321 | 0.040 | |
| negative regulation of cell proliferation involved in mesonephros development | GO:2000607 | 1 | 0.040 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.040 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.040 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.040 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.040 | |
| tendon formation | GO:0035992 | 4 | 0.040 | |
| primitive erythrocyte differentiation | GO:0060319 | 3 | 0.040 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.040 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.040 | |
| spermatogenesis | GO:0007283 | 284 | 0.040 | |
| cartilage development | GO:0051216 | 140 | 0.040 | |
| negative regulation of transcription by competitive promoter binding | GO:0010944 | 1 | 0.040 | |
| negative regulation of muscle cell differentiation | GO:0051148 | 33 | 0.040 | |
| positive regulation of transcription regulatory region dna binding | GO:2000679 | 1 | 0.040 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.039 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.039 | |
| chemotaxis | GO:0006935 | 247 | 0.039 | |
| negative regulation of osteoblast differentiation | GO:0045668 | 30 | 0.039 | Mouse |
| membrane organization | GO:0061024 | 245 | 0.039 | |
| urogenital system development | GO:0001655 | 261 | 0.039 | |
| cell migration involved in heart formation | GO:0060974 | 1 | 0.038 | |
| pigment metabolic process | GO:0042440 | 32 | 0.038 | Mouse |
| cation transport | GO:0006812 | 399 | 0.038 | |
| endocrine system development | GO:0035270 | 98 | 0.038 | |
| regulation of glial cell derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | GO:2000733 | 1 | 0.038 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.038 | |
| regulation of organ growth | GO:0046620 | 61 | 0.038 | |
| ovarian follicle development | GO:0001541 | 40 | 0.038 | |
| germ cell development | GO:0007281 | 185 | 0.038 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.038 | |
| growth plate cartilage chondrocyte growth | GO:0003430 | 2 | 0.038 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.037 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.037 | |
| tolerance induction | GO:0002507 | 14 | 0.037 | |
| digestive tract development | GO:0048565 | 190 | 0.037 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.037 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.037 | |
| mesoderm structural organization | GO:0048338 | 1 | 0.037 | |
| sulfur compound biosynthetic process | GO:0044272 | 37 | 0.037 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.037 | |
| heart valve morphogenesis | GO:0003179 | 21 | 0.037 | |
| protein catabolic process | GO:0030163 | 221 | 0.037 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.037 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.037 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.037 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.036 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.036 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.036 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.036 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.036 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.035 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.035 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.035 | |
| positive regulation of interleukin 13 production | GO:0032736 | 4 | 0.035 | |
| morphogenesis of an endothelium | GO:0003159 | 2 | 0.035 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.035 | |
| bronchus morphogenesis | GO:0060434 | 2 | 0.035 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.035 | |
| cell fate commitment | GO:0045165 | 210 | 0.035 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.034 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.034 | |
| pulmonary valve development | GO:0003177 | 5 | 0.034 | |
| mesodermal cell fate specification | GO:0007501 | 11 | 0.034 | |
| regulation of ossification | GO:0030278 | 112 | 0.034 | Mouse |
| amine metabolic process | GO:0009308 | 45 | 0.034 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.034 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.034 | |
| response to cholesterol | GO:0070723 | 4 | 0.034 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.034 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.034 | |
| negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | GO:2000703 | 1 | 0.034 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.034 | |
| atrial septum morphogenesis | GO:0060413 | 11 | 0.034 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.034 | |
| axial mesodermal cell fate commitment | GO:0048322 | 1 | 0.034 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.034 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.034 | |
| regulation of vascular wound healing | GO:0061043 | 2 | 0.034 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.033 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.033 | |
| sensory organ boundary specification | GO:0008052 | 1 | 0.033 | |
| nuclear transport | GO:0051169 | 139 | 0.033 | |
